Hair Relaxers' Cancer Risk; Genetic Test Aids Rural Care; Drug Negotiation Fallout?
(MedPage Today) -- Regular use of chemical hair relaxers by Black women increased their risk of uterine cancer by 50%. (Boston University, Environmental Research)
Adding the immune activator BXCL701 to pembrolizumab (Keytruda) significantly improved...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Boston University | Cancer | Cancer & Oncology | Cancer of the Uterus | Chemistry | Environmental Health | Genetics | Hematology | HIV AIDS | Rural Health | Women